Preferred Label : Surrogate Endpoint Biomarker;
Alternative definition : CDISC: A response biomarker that is an endpoint used in clinical trials as a substitute
for a direct measure of how a patient feels, functions, or survives. (NIH-FDA BEST
(Biomarkers, Endpoints, and other Tools) Resource);
Origin ID : C201366;
concept_is_in_subset
